Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition

• Published in: The Journal of biological chemistry Vol. 261; no. 21; pp. 9644 - 9651
• Main Authors: Coetzee, G A, Strachan, A F, van der Westhuyzen, D R, Hoppe, H C, Jeenah, M S, de Beer, F C
• Format: Journal Article
• Language: English
• Published: Bethesda, MD Elsevier Inc 25-07-1986; American Society for Biochemistry and Molecular Biology
• Subjects: Adult; Amyloid - blood; Analytical, structural and metabolic biochemistry; Apolipoproteins - blood; Biological and medical sciences; Centrifugation, Density Gradient; Cholesterol, HDL - blood; Densitometry; Electrophoresis, Polyacrylamide Gel; Female; Fundamental and applied biological sciences. Psychology; Humans; Immunosorbent Techniques; Lipoproteins, HDL - blood; Lipoproteins, HDL3; Lipoproteins, myelin; Male; Middle Aged; Proteins; Sepsis - blood; Serum Amyloid A Protein - blood; Ultracentrifugation; Human; Specific gravity; α-Lipoprotein; Molecular size; Apolipoproteins; Serum protein; Physicochemical properties
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/S0021-9258(18)67562-3

Serum amyloid A protein (apo-SAA), an acute phase reactant, is an apolipoprotein of high density lipoproteins (HDL), in particular the denser subpopulation HDL3. The structure of HDL3 isolated from humans affected by a variety of severe disease states was investigated with respect to density, size, and apolipoprotein composition, using density gradient ultracentrifugation, gradient gel electrophoresis, gel filtration, and solid phase immunoadsorption. Apo-SAA was present in HDL particles in increasing amounts as particle density increased. Apo-SAA-containing HDL3 had bigger radii than normal HDL3 of comparable density. Purified apo-SAA associated readily with normal HDL3 in vitro, giving rise to particles containing up to 80% of their apoproteins as apo-SAA. The addition of apo-SAA resulted in a displacement of apo-A-I and an increase in particle size. Acute phase HDL3 represented a mixture of particles, polydisperse with respect to apolipoprotein content; for example, some particles were isolated that contained apo-A-I, apo-A-II, and apo-SAA, whereas others contained apo-A-I and apo-SAA but no apo-A-II. We conclude that apo-SAA probably associates in the circulation of acute phase patients with existing HDL particles, causing the remodeling of the HDL shell to yield particles of bigger size and higher density that are relatively depleted of apo-A-I.